sparfloxacin has been researched along with Soft Tissue Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henry, DC; Lipsky, BA; Magner, DJ; McCabe, A; Miller, B; Nolan, T; Schwartz, R; Talbot, GH | 1 |
| Blatun, LA; Grishina, IA; Iakovlev, VP; Izotova, GN; Krutikov, MG | 1 |
2 trial(s) available for sparfloxacin and Soft Tissue Infections
| Article | Year |
|---|---|
Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Skin Diseases, Infectious; Soft Tissue Infections | 1999 |
[Clinical and laboratory efficacy of the novel difluoroquinolone Sparflo (sparfloxacin) in therapy of skin and soft tissue infections].
Topics: Acinetobacter; Adolescent; Adult; Aged; Anti-Infective Agents; Burns; Female; Fluoroquinolones; Humans; Male; Middle Aged; Proteus mirabilis; Soft Tissue Infections; Staphylococcus; Surgical Wound Infection | 2000 |